Discovery and comparison of serum biomarkers for diabetes mellitus and metabolic syndrome based on UPLC-Q-TOF/MS
基于UPLC-Q-TOF / MS的糖尿病及代谢综合征血清生物标志物的发现与比较
作者: Xuan LiuXiuqing GaoRui ZhangZiyan LiuNa ShenYanbo DiTao FangHuanming LiFengshi Tian
作者单位: 1Pharmacy Department, Tianjin 4th Center Hospital, Tianjin 300140, China
2Central Laboratory, Tianjin 4th Center Hospital, Tianjin 300140, China
3Department of Cardiology, Tianjin 4th Center Hospital, Tianjin 300140, China
4Hospital Acquired Infection Control Department, Tianjin 4th Center Hospital, Tianjin 300140, China
5Tianjin Fourth Central Hospital, Tianjin 300140, China
刊名: Clinical Biochemistry, 2020
来源数据库: Elsevier Journal
DOI: 10.1016/j.clinbiochem.2020.03.007
关键词: Diabetes mellitusMetabolic syndromeBiomarkersDifferencePathway
英文摘要: Abstract(#br)Introduction(#br)Diabetes mellitus (DM) and metabolic syndrome (MetS) are systemic metabolic disorders, which have risk factors for diabetic cardiovascular and cerebral microvascular disease. It is very important to screen the metabolic biomarkers between DM and MetS patients, which can make patients benefit to a greater extent and prevent the occurrence of disease in advance.(#br)Objectives(#br)Diabetes mellitus (DM) and metabolic syndrome are a complex, chronic illness with a pronounced impact on the quality of life of many people. However, understanding the metabolic changes in patients and identifying high-risk individuals is crucial for prevention and disease management strategies.(#br)Methods(#br)In this study, a nontargeted metabolomics approach based on UPLC-Q-TOF/MS...
全文获取路径: Elsevier  (合作)
分享到:
来源刊物:
影响因子:2.45 (2012)

×
关键词翻译
关键词翻译
  • diabetes 糖尿病
  • syndrome 症候群
  • metabolic 新陈代谢的
  • serum 血清
  • TOF Time Of Filling
  • based 基于
  • comparison 比较